Back

Impact of ACE inhibitor and ARB use on long-term limb outcomes in patients with established peripheral artery disease: Insights from the REACH Registry

29 August 2016 (14:30 - 14:40)
Organised by:
Congress Presentation Part of: New insights on peripheral circulation Medical treatment ESC Premium Access ESC Congress 2016

About the speaker

Photo
Assistant Professor Dharam Kumbhani

UT Southwestern Medical Center, Dallas (United States of America)

8 More presentations in this session

Presentation thumbnail
Cardiovascular outcome in patients with peripheral artery disease (pad) as initial manifestation of atherosclerotic disease compared with patients with pad as subsequent diagnosis after coronary heart
Doctor B. Sigvant (Karlstad, SE)
Abstract Slides Video
Presentation thumbnail
Long-term mortality and major adverse cardiovascular events in patients with borderline ankle brachial index: a 15-year follow-up study
Associate Professor B. Yan (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Resting heart rate is an independent predictor of mortality in patients with peripheral artery disease
Assistant Professor B. Jug (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Transradial approach for carotid artery stenting in high-risk patients
Doctor D. Petkoska (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Usefulness of ultrasonography in endovascular therapy for chronic total occlusion of femoro-popliteal arteries
Doctor H. Takimura (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New insights on peripheral circulation

The Event

Event poster

ESC Congress 2016

29 August 2016 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Navigating lower limb PAD diagnosis and treatment
2 September 2024
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Presentation
Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia
28 August 2020
thumbnail
Congress Presentation
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources